Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antifungal
    (1)
  • Others
    (3)
TargetMol | Tags By Natures
  • Bacopa
    (3)
TargetMol | Tags By ResearchField
  • Nervous System
    (2)
  • Cancer
    (1)
Filter
Search Result
Results for "

bacopaside v

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Natural Products
    4
    TargetMol | Natural_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
  • Bacopaside V
    TN1423620592-16-7
    Bacopaside V is a bioactive triterpenoid glycoside of Bacopa monnieri, a herb having confirmed nervine tonic activity. Bacopaside V is studied in phytochemical and neurobiological research contexts focusing on triterpenoid glycoside diversity and central nervous system–associated signaling models. Bacopaside V is also applied in experimental systems investigating saponin-derived metabolite behavior and neuroactive compound profiling in plant-derived bioactive compound research.
    • $320
    In Stock
    Size
    QTY
  • Bacopaside V (Standard)
    TMSM-2102620592-16-7
    Bacopaside V (Standard) is a reference standard for research and analysis in studies involving Bacopaside V. Bacopaside V is a natural product
    • $1,350
    7-10 days
    Size
    QTY
  • Bacopaside VI
    TN8852935756-71-1
    Bacopaside VI is a major bioactive triterpenoid saponin isolated from Bacopa monnieri. Bacopaside VI is utilized in biomedical research focused on plant-derived triterpenoid saponin characterization, neurochemical pathway modeling, and phytochemical analysis of complex botanical extracts.
    • $195
    In Stock
    Size
    QTY
  • Bacopaside X
    Bacopaside VII
    TN142494443-88-6
    Bacopaside X is a triterpenoid saponin isolated from Bacopa monniera that exhibits strong antifungal and anticancer activities by actively suppressing pathogenic fungal growth and tumor progression, demonstrated through inhibition of Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus at MIC values of 50 µg/ml, along with significantly decreasing proliferation in cancer cell lines MDA-MB-231, SHG44, HCT8, A549, and PC3M with IC50 values of 14.3, 15.9, 9.8, 9.7, and 10.1 µM respectively. Bacopaside X additionally reduces tumor growth by 84.13% in an S180 sarcoma mouse allograft model when administered at a dose of 50 µmol/kg, indicating substantial therapeutic potential.
    • $57
    In Stock
    Size
    QTY